Stock Track | Nanobiotix (NBTX) Soars 5.07% as Jefferies Triples Price Target

Stock Track10-06

Shares of Nanobiotix (NASDAQ: NBTX), a biotechnology company, are soaring 5.07% in pre-market trading on Monday. The stock's upward movement comes on the heels of a significant price target upgrade from a major Wall Street firm.

Jefferies, a prominent investment bank and financial services company, has substantially raised its target price for Nanobiotix. The firm increased its price target from $8.3 to $24.7, representing a nearly threefold increase. This bullish outlook from Jefferies appears to be the primary catalyst for the stock's pre-market rally.

The dramatic increase in the price target suggests that Jefferies analysts have become significantly more optimistic about Nanobiotix's future prospects. While the specific reasons for the upgrade were not provided in the available news, such a substantial revision often indicates positive developments in a company's pipeline, financial outlook, or market potential. Investors will likely be watching closely for any additional information or announcements from Nanobiotix in the coming days to better understand the factors driving this newfound optimism.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1176581307?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-06 22:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176581307","market":"sg","top_or_hot":-1,"title":"Stock Track | Nanobiotix (NBTX) Soars 5.07% as Jefferies Triples Price Target","media":"Stock Track","content":"<p>Shares of Nanobiotix (NASDAQ: NBTX), a biotechnology company, are soaring 5.07% in pre-market trading on Monday. The stock's upward movement comes on the heels of a significant price target upgrade from a major Wall Street firm.</p>\n\n<p>Jefferies, a prominent investment bank and financial services company, has substantially raised its target price for Nanobiotix. The firm increased its price target from $8.3 to $24.7, representing a nearly threefold increase. This bullish outlook from Jefferies appears to be the primary catalyst for the stock's pre-market rally.</p>\n\n<p>The dramatic increase in the price target suggests that Jefferies analysts have become significantly more optimistic about Nanobiotix's future prospects. While the specific reasons for the upgrade were not provided in the available news, such a substantial revision often indicates positive developments in a company's pipeline, financial outlook, or market potential. Investors will likely be watching closely for any additional information or announcements from Nanobiotix in the coming days to better understand the factors driving this newfound optimism.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Nanobiotix (NBTX) Soars 5.07% as Jefferies Triples Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Nanobiotix (NBTX) Soars 5.07% as Jefferies Triples Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-06 22:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Nanobiotix (NASDAQ: NBTX), a biotechnology company, are soaring 5.07% in pre-market trading on Monday. The stock's upward movement comes on the heels of a significant price target upgrade from a major Wall Street firm.</p>\n\n<p>Jefferies, a prominent investment bank and financial services company, has substantially raised its target price for Nanobiotix. The firm increased its price target from $8.3 to $24.7, representing a nearly threefold increase. This bullish outlook from Jefferies appears to be the primary catalyst for the stock's pre-market rally.</p>\n\n<p>The dramatic increase in the price target suggests that Jefferies analysts have become significantly more optimistic about Nanobiotix's future prospects. While the specific reasons for the upgrade were not provided in the available news, such a substantial revision often indicates positive developments in a company's pipeline, financial outlook, or market potential. Investors will likely be watching closely for any additional information or announcements from Nanobiotix in the coming days to better understand the factors driving this newfound optimism.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NBTX","symbol_name":"NANOBIOTIX SPON ADS EACH REP 1 ORD SHS","start_time":0,"source_url":"","article_id":"1176581307","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176581307","pubTimestamp":1759759338,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Nanobiotix (NASDAQ: NBTX), a biotechnology company, are soaring 5.07% in pre-market trading on Monday. The stock's upward movement comes on the heels of a significant price target upgrade...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NBTX":"NANOBIOTIX SPON ADS EACH REP 1 ORD SHS"},"translate_title":"股票追踪|Jefferies将目标价提高两倍，Nanobiotix(NBTX)飙升5.07%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NBTX":1},"content_text":"Shares of Nanobiotix (NASDAQ: NBTX), a biotechnology company, are soaring 5.07% in pre-market trading on Monday. The stock's upward movement comes on the heels of a significant price target upgrade from a major Wall Street firm.\nJefferies, a prominent investment bank and financial services company, has substantially raised its target price for Nanobiotix. The firm increased its price target from $8.3 to $24.7, representing a nearly threefold increase. This bullish outlook from Jefferies appears to be the primary catalyst for the stock's pre-market rally.\nThe dramatic increase in the price target suggests that Jefferies analysts have become significantly more optimistic about Nanobiotix's future prospects. While the specific reasons for the upgrade were not provided in the available news, such a substantial revision often indicates positive developments in a company's pipeline, financial outlook, or market potential. Investors will likely be watching closely for any additional information or announcements from Nanobiotix in the coming days to better understand the factors driving this newfound optimism.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1176581307","isCrawlerRequest":true}